Rani Therapeutics Holdings (RANI) Amortizatization of Intangibles (2022 - 2026)

Rani Therapeutics Holdings' (RANI) quarterly Amortizatization of Intangibles came in at $244000.0 in Q1 2026, up 62.67% year-on-year from $150000.0 in Q1 2025, and up 103.33% quarter-over-quarter from $120000.0 in Q4 2025.

Rani Therapeutics Holdings (RANI) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends

Rani Therapeutics Holdings' Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $244000.0 for Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles rose 62.67% year-over-year to $244000.0 in Q1 2026; TTM through Mar 2026 was $372000.0, a 64.81% decrease from a year earlier, with the FY2025 full-year figure at $278000.0, down 77.71% from the prior year.
  • Amortizatization of Intangibles grew to $244000.0 in Q1 2026 per RANI's latest filing, from $120000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $699000.0 in Q1 2023 and bottomed at $8000.0 in Q2 2025.
  • The 5-year median for Amortizatization of Intangibles is $308500.0 (2024), against an average of $352571.4.
  • Across the five-year window, Amortizatization of Intangibles jumped 190.0% in 2023 and tumbled 97.24% in 2025, its largest moves.
  • Year by year, Amortizatization of Intangibles stood at $641000.0 in 2022, then dropped by 27.46% to $465000.0 in 2023, then slumped by 33.98% to $307000.0 in 2024, then plunged by 60.91% to $120000.0 in 2025, then soared by 103.33% to $244000.0 in 2026.
  • Per Business Quant, the three latest RANI Amortizatization of Intangibles figures stand at $244000.0 (Q1 2026), $120000.0 (Q4 2025), and $8000.0 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Rani Therapeutics Holdings 144.81 Mn 144.81 Mn - 244,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 244,000.00
Mar 31, 2026 244,000.00
Dec 31, 2025 120,000.00
Dec 31, 2025 120,000.00
Jun 30, 2025 8,000.00
Jun 30, 2025 8,000.00
Mar 31, 2025 150,000.00
Mar 31, 2025 150,000.00
Dec 31, 2024 307,000.00
Dec 31, 2024 307,000.00
Sep 30, 2024 310,000.00
Sep 30, 2024 310,000.00
Jun 30, 2024 290,000.00
Jun 30, 2024 290,000.00
Mar 31, 2024 340,000.00
Mar 31, 2024 340,000.00
Dec 31, 2023 465,000.00
Dec 31, 2023 465,000.00
Sep 30, 2023 609,000.00
Sep 30, 2023 609,000.00